Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs)

被引:5
|
作者
Szabo, Gyorgy [1 ]
Kolok, Sandor [1 ]
Orgovan, Zoltan [2 ]
Vastag, Monika [1 ]
Beni, Zoltan [1 ]
Koti, Janos [1 ]
Saghy, Katalin [1 ]
Levay, Gyorgy I. [1 ]
Greiner, Istvan [1 ]
Keseru, Gyorgy M. [2 ]
机构
[1] Gedeon Richter Plc, 19-21 Gyomroi Ut, H-1103 Budapest, Hungary
[2] Hungarian Acad Sci, Res Ctr Nat Sci, Med Chem Res Grp, 2 Magyar Tudosok Korutja, H-1117 Budapest, Hungary
关键词
mGlu(2) receptor; Positive allosteric modulator; Scaffold hopping; Dihydropyrazino-benzimidazoles; Pharmacophore based optimization; SCHIZOPHRENIA; PHARMACOPHORE; PHARMACOLOGY; AGONIST;
D O I
10.1016/j.ejmech.2019.111881
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A scaffold hopping strategy converted the known 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidine core (1 and 2) by cyclization to a fused [6 + 5+6] membered heterocyclic mGluR2 PAM scaffold. Pharmacophore guided structure-activity relationship (SAR) studies resulted in a series of potent and metabolically stable mGluR2 PAMs. A representative optimized compound (95) having the most balanced profile, demonstrated efficacy in the PCP-induced hyper-locomotion model in mice that revealed the new chemotype being a promising PAM lead targeting mGluR2 receptors and providing support for further translational studies. (C) 2019 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Discovery of dihydropyrrolopyrazinone derivatives as metabotropic glutamate receptor 2 (mGluR2) positive allosteric modulators (PAMs)
    Tsuda, Yusuke
    Fukaya, Takayuki
    Masuda, Takahiro
    Sugishita, Aiko
    Sumitomo, Masako
    Kitamura, Atsushi
    Nishimura, Naohiro
    Masumoto, Shuji
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 247
  • [2] Positive allosteric modulators of the metabotropic glutamate receptor subtype 2 (mGluR2)
    Rudd, MT
    McCauley, JA
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (09) : 869 - 884
  • [3] Positive Allosteric Modulators (PAMs) of Metabotropic Glutamate Receptor 2 (mGluR2) are Effective in Nerve Injury-Induced Facial Allodynia in Rats
    Horvath, Cs.
    Galgoczy, K.
    Kordas, K. Sz.
    Kis-Varga, A.
    Turos, Gy
    Szabo, Gy
    Gal, K.
    CURRENT NEUROPHARMACOLOGY, 2014, 12 : 26 - 26
  • [4] Positive allosteric modulators (PAMS) of the metabotropic glutamate receptor 2 (MGLUR2) are effective against nerve injury induced facial allodynia in rats
    Horvath, C.
    Galgoczy, K.
    Kordas, K.
    Kis-Varga, A.
    Turos, G.
    Szabo, G.
    JOURNAL OF HEADACHE AND PAIN, 2014, 15
  • [5] Design, synthesis, and evaluation of novel metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulators (PAMs): Refinement of SAR
    Sidique, Shyama
    Sheffler, Douglas
    Nickols, Hilary Highfield
    D'Souza, Manoranjan
    Yang, Li
    Dahl, Russell
    Semenova, Svetlana
    Markou, Athina
    Conn, Jeffrey
    Cosford, Nicholas D. P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [6] Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor
    Garbaccio, Robert M.
    Brnardic, Edward J.
    Fraley, Mark E.
    Hartman, George D.
    Hutson, Pete H.
    O'Brien, Julie A.
    Magliaro, Brian C.
    Uslaner, Jason M.
    Huszar, Sarah L.
    Fillgrove, Kerry L.
    Small, James H.
    Tang, Cuyue
    Kuo, Yuhsin
    Jacobson, Marlene A.
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (08): : 406 - 410
  • [7] Fragment Based Optimization of Metabotropic Glutamate Receptor 2 (mGluR2) Positive Allosteric Modulators in the Absence of Structural Information
    Szabo, Gyorgy
    Turos, Gyorgy I.
    Kolokt, Sandor
    Vastag, Monika
    Santa, Zsuzsanna
    Dekany, Miklos
    Levay, Gyorgy I.
    Greiner, Istvan
    Natsumi, Minami
    Tatsuya, Watanabe
    Keseru, Gyorgy M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (01) : 234 - 246
  • [8] Effectiveness of positive allosteric modulators of metabotropic glutamate receptor 2/3 (mGluR2/3) in animal models of schizophrenia
    Olivares-Berjaga, David
    Martinez-Pinteno, Albert
    Rodriguez, Natalia
    Mas, Sergi
    Moren, Constanza
    Parellada, Eduard
    Gasso, Patricia
    TRANSLATIONAL PSYCHIATRY, 2025, 15 (01):
  • [9] Design, synthesis, and evaluation of novel biphenyl indanone-A (BINA) derivatives that are metabotropic glutamate receptor subtype-2 (mGluR2) positive allosteric modulators (PAMs): Incorporation of heteroatoms
    Dhanya, R.
    Sheffler, Douglas
    Dahl, Russel
    Yang, Li
    Semenova, Svetlana
    Zin, Xinchun
    Markou, Athina
    Conn, Jeffrey P.
    Cosford, Nicholas D. P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [10] Arylsulphonamides as positive allosteric modulators of the mGluR2 receptor
    Doherty, J
    Field, J
    Frey, J
    Isaac, M
    Johnson, E
    Levinthal, C
    Mathisen, B
    Mrzljak, L
    Radhakrishnan, V
    Slassi, A
    Spence, KT
    Stormann, T
    Subramaniam, R
    Sun, G
    Urbanek, R
    VanWagenen, B
    Wilson, J
    Zhu, G
    Egle, I
    NEUROPHARMACOLOGY, 2005, 49 : 242 - 243